English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Researchers at UT Arlington launch study on health effects of hookah smoking methods

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Review examines why antidepressants often fail in Alzheimer’s and Parkinson’s depression

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

New review highlights potential of TCM polysaccharide hydrogels for wound healing

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Researchers report antibody-drug conjugate eradicates residual leukemia in clinical trial

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Compass Pathways reports durable results for psilocybin depression drug in late-stage trial

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Researchers find infants begin moving to music within their first year

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Bristol Myers Squibb’s Krazati fails to improve survival in colorectal cancer trial

+ Pharmaceuticals
Patient Daily | Jul 7, 2026

Hengrui and Kailera report positive late-stage results for oral GLP-1 in China trials

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily